Insight into the Assembling Mechanism of Cryptococcus Capsular Glucuronoxylomannan Based on Molecular Dynamics Simulations
- PMID: 33225166
- PMCID: PMC7676341
- DOI: 10.1021/acsomega.0c04164
Insight into the Assembling Mechanism of Cryptococcus Capsular Glucuronoxylomannan Based on Molecular Dynamics Simulations
Abstract
Cryptococcus spp. is an invasive fungal pathogen and causes life-threatening cryptococcosis. Opportunistic cryptococcal infections among the immunocompromised population are mostly caused by Cryptococcus neoformans, whereas the geographical dissemination of Cryptococcus gattii in recent years has threatened lives of even immunocompetent people. The capsule, mainly composed of glucuronoxylomannan (GXM) polysaccharides, plays important roles in the virulence of Cryptococcus spp. The assembling mechanism of GXM polysaccharides into the capsule is little understood because of insufficient experimental data. Molecular modeling and molecular dynamics simulation provide insight into the assembling process. We first built GXM oligosaccharide models of serotypes D, A, B, and C and extracted their secondary structure information from simulation trajectories. All the four mainchains tend to take the nearly twofold helical conformation, whereas peripheral sidechains prefer to form left-handed helices, which are further stabilized by intramolecular hydrogen bonds. Based on the obtained secondary structure information, GXM polysaccharide arrays were built to simulate capsule-assembling processes of C. neoformans and C. gattii using serotypes A and C as representatives, respectively. Trajectory analysis illustrates that electrostatic neutralization of acidic sidechain residues of GXM is a prerequisite for capsule assembling, followed by formation of intermolecular hydrogen bond networks. Further insight into the assembling mechanism of GXM polysaccharides provides the possibility to develop novel treatment and prevention solutions for cryptococcosis.
© 2020 American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures




Similar articles
-
A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.Infect Immun. 2019 Mar 25;87(4):e00731-18. doi: 10.1128/IAI.00731-18. Print 2019 Apr. Infect Immun. 2019. PMID: 30670549 Free PMC article.
-
Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.Cytotherapy. 2021 Feb;23(2):119-130. doi: 10.1016/j.jcyt.2020.11.002. Epub 2020 Dec 7. Cytotherapy. 2021. PMID: 33303326 Free PMC article.
-
Dectin-3 Recognizes Glucuronoxylomannan of Cryptococcus neoformans Serotype AD and Cryptococcus gattii Serotype B to Initiate Host Defense Against Cryptococcosis.Front Immunol. 2018 Aug 6;9:1781. doi: 10.3389/fimmu.2018.01781. eCollection 2018. Front Immunol. 2018. PMID: 30131805 Free PMC article.
-
Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans.Front Med (Lausanne). 2019 Jun 19;6:129. doi: 10.3389/fmed.2019.00129. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31275938 Free PMC article. Review.
-
The Overlooked Glycan Components of the Cryptococcus Capsule.Curr Top Microbiol Immunol. 2019;422:31-43. doi: 10.1007/82_2018_140. Curr Top Microbiol Immunol. 2019. PMID: 30203395 Review.
Cited by
-
Role of glucuronoxylomannan and steryl glucosides in protecting against cryptococcosis.mBio. 2025 Jun 11;16(6):e0098425. doi: 10.1128/mbio.00984-25. Epub 2025 Apr 29. mBio. 2025. PMID: 40298449 Free PMC article.
-
Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen.ACS Infect Dis. 2024 Feb 9;10(2):475-488. doi: 10.1021/acsinfecdis.3c00447. Epub 2023 Oct 19. ACS Infect Dis. 2024. PMID: 37856427 Free PMC article.
-
Broad Antifungal Spectrum of the Pore-Forming Peptide C14R Against Cryptococcus and Candida Species from the WHO Fungal Priority Pathogens List.Pathogens. 2025 May 22;14(6):511. doi: 10.3390/pathogens14060511. Pathogens. 2025. PMID: 40559519 Free PMC article.
References
-
- de Aguiar P. A. D. F.; Pedroso R. D. S.; Borges A. S.; de Aquino Moreira T.; de Araújo L. B.; de Brito Röder D. V. D. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital. Rev. Inst. Med. Trop. Sao Paulo 2017, 59, e13–e21. 10.1590/s1678-9946201759013. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous